KIAA1210: A Potential Drug Target Or Biomarker (G57481)

Target Name: KIAA1210

NCBI ID: G57481

KIAA1210

KIAA1210: A Potential Drug Target Or Biomarker

KIAA1210 is a protein that is expressed in many different tissues throughout the body, including the brain. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues such as the skin, hair, nails, and bones.

Recent studies have suggested that KIAA1210 may have potential as a drug target or biomarker. One reason for this is that KIAA1210 has been shown to play a role in the regulation of cell proliferation and differentiation. In fact, studies have shown that KIAA1210 levels are highly elevated in cancer cells, and that inhibiting its activity may be a promising strategy for the treatment of cancer.

Another potential reason for the interest in KIAA1210 is its role in the regulation of the immune system. KIAA1210 has been shown to be involved in the development and function of immune cells, and may be a target for drugs that are designed to enhance or inhibit the immune response.

In addition to its potential as a drug target or biomarker, KIAA1210 is also of interest as a potential therapeutic agent for a variety of other conditions. For example, KIAA1210 has been shown to be involved in the regulation of cell adhesion, and may be a useful agent for the treatment of conditions such as heart disease and neurodegenerative diseases.

Overall, KIAA1210 is a protein that has significant potential as a drug target or biomarker, and is the subject of ongoing research in the scientific community. Further studies are needed to fully understand its role and potential as a therapeutic agent.

Protein Name: KIAA1210

The "KIAA1210 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIAA1210 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets